Year |
Citation |
Score |
2016 |
Shackleton B, Crawford F, Bachmeier C. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding. Fluids and Barriers of the Cns. 13: 14. PMID 27503326 DOI: 10.1186/S12987-016-0038-X |
0.345 |
|
2013 |
Bachmeier C, Levin GM, Beaulieu-Abdelahad D, Reed J, Mullan M. Effect of venlafaxine and desvenlafaxine on drug efflux protein expression and biodistribution in vivo. Journal of Pharmaceutical Sciences. 102: 3838-43. PMID 23897419 DOI: 10.1002/Jps.23680 |
0.618 |
|
2013 |
Bachmeier C, Beaulieu-Abdelahad D, Mullan M, Paris D. Role of the cannabinoid system in the transit of beta-amyloid across the blood-brain barrier. Molecular and Cellular Neurosciences. 56: 255-62. PMID 23831388 DOI: 10.1016/J.Mcn.2013.06.004 |
0.301 |
|
2013 |
On NH, Mitchell R, Savant SD, Bachmeier CJ, Hatch GM, Miller DW. Examination of blood-brain barrier (BBB) integrity in a mouse brain tumor model. Journal of Neuro-Oncology. 111: 133-43. PMID 23184143 DOI: 10.1007/s11060-012-1006-1 |
0.476 |
|
2011 |
Bachmeier CJ, Beaulieu-Abdelahad D, Ganey NJ, Mullan MJ, Levin GM. Induction of drug efflux protein expression by venlafaxine but not desvenlafaxine. Biopharmaceutics & Drug Disposition. 32: 233-44. PMID 21446053 DOI: 10.1002/bdd.753 |
0.65 |
|
2010 |
Bachmeier C, Mullan M, Paris D. Characterization and use of human brain microvascular endothelial cells to examine β-amyloid exchange in the blood-brain barrier. Cytotechnology. 62: 519-29. PMID 20954006 DOI: 10.1007/S10616-010-9313-X |
0.365 |
|
2007 |
Chavanpatil MD, Khdair A, Gerard B, Bachmeier C, Miller DW, Shekhar MP, Panyam J. Surfactant-polymer nanoparticles overcome P-glycoprotein-mediated drug efflux. Molecular Pharmaceutics. 4: 730-8. PMID 17705442 DOI: 10.1021/Mp070024D |
0.577 |
|
2006 |
Bachmeier CJ, Trickler WJ, Miller DW. Comparison of drug efflux transport kinetics in various blood-brain barrier models. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 34: 998-1003. PMID 16554372 DOI: 10.1124/dmd.105.006999 |
0.617 |
|
2005 |
Bachmeier CJ, Spitzenberger TJ, Elmquist WF, Miller DW. Quantitative assessment of HIV-1 protease inhibitor interactions with drug efflux transporters in the blood-brain barrier. Pharmaceutical Research. 22: 1259-68. PMID 16078135 DOI: 10.1007/s11095-005-5271-y |
0.672 |
|
2005 |
Bachmeier CJ, Miller DW. A fluorometric screening assay for drug efflux transporter activity in the blood-brain barrier. Pharmaceutical Research. 22: 113-21. PMID 15771237 DOI: 10.1007/s11095-004-9016-0 |
0.674 |
|
2004 |
Bachmeier CJ, Trickler WJ, Miller DW. Drug efflux transport properties of 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM) and its fluorescent free acid, BCECF. Journal of Pharmaceutical Sciences. 93: 932-42. PMID 14999730 DOI: 10.1002/jps.20018 |
0.617 |
|
2003 |
Zhang Y, Bachmeier C, Miller DW. In vitro and in vivo models for assessing drug efflux transporter activity. Advanced Drug Delivery Reviews. 55: 31-51. PMID 12535573 DOI: 10.1016/S0169-409X(02)00170-9 |
0.668 |
|
Show low-probability matches. |